Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 546 (7657), 312-315

Human GLP-1 Receptor Transmembrane Domain Structure in Complex With Allosteric Modulators

Affiliations

Human GLP-1 Receptor Transmembrane Domain Structure in Complex With Allosteric Modulators

Gaojie Song et al. Nature.

Abstract

The glucagon-like peptide-1 receptor (GLP-1R) and the glucagon receptor (GCGR) are members of the secretin-like class B family of G-protein-coupled receptors (GPCRs) and have opposing physiological roles in insulin release and glucose homeostasis. The treatment of type 2 diabetes requires positive modulation of GLP-1R to inhibit glucagon secretion and stimulate insulin secretion in a glucose-dependent manner. Here we report crystal structures of the human GLP-1R transmembrane domain in complex with two different negative allosteric modulators, PF-06372222 and NNC0640, at 2.7 and 3.0 Å resolution, respectively. The structures reveal a common binding pocket for negative allosteric modulators, present in both GLP-1R and GCGR and located outside helices V-VII near the intracellular half of the receptor. The receptor is in an inactive conformation with compounds that restrict movement of the intracellular tip of helix VI, a movement that is generally associated with activation mechanisms in class A GPCRs. Molecular modelling and mutagenesis studies indicate that agonist positive allosteric modulators target the same general region, but in a distinct sub-pocket at the interface between helices V and VI, which may facilitate the formation of an intracellular binding site that enhances G-protein coupling.

Comment in

Similar articles

See all similar articles

Cited by 33 articles

See all "Cited by" articles

References

    1. Mol Endocrinol. 1997 Apr;11(4):424-32 - PubMed
    1. Biochem Pharmacol. 2015 Aug 1;96(3):237-46 - PubMed
    1. Diabetes. 2010 Dec;59(12):3099-107 - PubMed
    1. Acta Crystallogr D Biol Crystallogr. 2010 Apr;66(Pt 4):486-501 - PubMed
    1. Trends Pharmacol Sci. 2014 Jan;35(1):12-22 - PubMed

Publication types

MeSH terms

LinkOut - more resources

Feedback